Medical tourism is booming, but its hidden costs are quietly straining the NHS. A recent rapid review published in BMJ Open reveals that postoperative complications from surgeries performed abroad could be costing the NHS up to £20,000 per patient. But here's where it gets controversial: the data on this issue is shockingly incomplete, leaving us in the dark about the true risks and financial impact of seeking treatment overseas.
The allure of affordable or specialized procedures abroad has driven a steady rise in medical tourism over the decades, with no signs of slowing down. However, when complications arise—and they often do—it’s the patient’s home country, like the UK, that bears the burden of treatment. And this is the part most people miss: the lack of detailed information about the initial surgery can make treating these complications even more challenging.
Researchers set out to assess the costs, savings, and complications associated with medical tourism for the NHS. They scoured databases and 'grey literature'—think conference papers, government reports, and industry insights—published between 2012 and 2024. Notably, they excluded studies on emergency surgeries, cancer treatments, infertility procedures, dentistry, and transplant surgeries to focus on elective procedures.
Out of 90 articles reviewed, 38 studies made the cut, covering complications from metabolic/bariatric surgery (19), cosmetic surgery (17), and eye surgery (1). These studies included 655 patients treated by the NHS between 2011 and 2024 for complications arising from these procedures. Turkey emerged as the most popular destination, accounting for 61% of cases, with women making up 90% of patients and the average age being 38.
The most common procedures were sleeve gastrectomy (stomach reduction), breast enlargement, and abdominoplasty ('tummy tuck'). While no deaths were reported, at least 53% of patients experienced moderate to severe complications. Treatment details were often unclear, and only 14 studies reported costs, ranging from £1,058 to £19,549 per patient in 2024 prices.
Hospital stays for complications were lengthy: an average of 17 days for metabolic/bariatric surgery and nearly 6 days for cosmetic surgery. Eye surgery complications required over 50 outpatient appointments and 4 additional procedures. Yet, very few studies tracked other resource use, like diagnostic tests or clinic visits.
The evidence from these studies is largely uncertain, as most were retrospective and relied on potentially incomplete medical notes. This raises a critical question: Are we underestimating the risks and costs of medical tourism? Researchers highlight gaps in data, particularly from regions like Wales and South West England, and the lack of long-term follow-up studies.
Without comprehensive data, it’s impossible to fully grasp the risks patients face when opting for surgery abroad. Should the NHS bear the burden of these complications, or should patients be held more accountable? A systematic approach to data collection is urgently needed, along with public awareness campaigns to educate UK residents about the potential pitfalls of medical tourism.
Patients considering treatment abroad should be fully informed about which complications the NHS will cover and which costs they might personally incur. What do you think? Is medical tourism worth the risk, or should stricter regulations be in place? Share your thoughts in the comments below.
